These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18378837)

  • 1. Benzodiazepine use and expenditures for Medicare beneficiaries and the implications of Medicare Part D exclusions.
    Yang HW; Simoni-Wastila L; Zuckerman IH; Stuart B
    Psychiatr Serv; 2008 Apr; 59(4):384-91. PubMed ID: 18378837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the Medicare Part D benzodiazepine exclusion on the utilization patterns of benzodiazepines and substitute medications.
    Chen YC; Kreling DH
    Res Social Adm Pharm; 2014; 10(2):438-47. PubMed ID: 23880428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Medicare Part D Benzodiazepine Coverage Expansion With Changes in Fall-Related Injuries and Overdoses Among Medicare Advantage Beneficiaries.
    Maust DT; Lin LA; Goldstick JE; Haffajee RL; Brownlee R; Bohnert ASB
    JAMA Netw Open; 2020 Apr; 3(4):e202051. PubMed ID: 32242907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D.
    Blumberg DM; Prager AJ; Liebmann JM
    JAMA Ophthalmol; 2016 Feb; 134(2):212-20. PubMed ID: 26720853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicare part D's exclusion of benzodiazepines and fracture risk in nursing homes.
    Briesacher BA; Soumerai SB; Field TS; Fouayzi H; Gurwitz JH
    Arch Intern Med; 2010 Apr; 170(8):693-8. PubMed ID: 20421554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicare Part D benzodiazepine exclusion and use of psychotropic medication by patients with new anxiety disorders.
    Ong MK; Zhang L; Xu H; Azocar F; Ettner SL
    Psychiatr Serv; 2012 Jul; 63(7):637-42. PubMed ID: 22549332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug use patterns in severely mentally ill Medicare beneficiaries: impact of discontinuities in drug coverage.
    Simoni-Wastila L; Zuckerman IH; Shaffer T; Blanchette CM; Stuart B
    Health Serv Res; 2008 Apr; 43(2):496-514. PubMed ID: 18370965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Medicare Part D on Prescription Drug Spending and Health Care Use: 6 Years of Follow-up, 2007-2012.
    Park T; Jung J
    J Manag Care Spec Pharm; 2017 Jan; 23(1):5-12. PubMed ID: 28025927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year impact of Medicare Part D coverage gap reform on drug expenditures and utilization.
    Park J; Look KA
    Health Serv Res; 2022 Feb; 57(1):56-65. PubMed ID: 33870486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer history, insurance coverage, and cost-related medication nonadherence in Medicare beneficiaries, 2013-2018.
    Li M; Bounthavong M
    J Manag Care Spec Pharm; 2021 Dec; 27(12):1750-1756. PubMed ID: 34818087
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of medicare part D benzodiazepine exclusion on psychotropic use in benzodiazepine users.
    Ong MK; Xu H; Zhang L; Azocar F; Ettner SL
    J Am Geriatr Soc; 2012 Jul; 60(7):1292-7. PubMed ID: 22725849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of unused prescription opioids and benzodiazepines remaining after death among Medicare decedents.
    Baum LVM; Bruzelius E; Kiang MV; Humphreys K; Basu S; Baum A
    Drug Alcohol Depend; 2021 Feb; 219():108502. PubMed ID: 33421803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with psychotropic prescriptions, psychiatric hospitalization, and spending among Medicare beneficiaries under 65.
    Qian J; Wittayanukorn S; McGuffey G; Hansen R
    Disabil Health J; 2015 Jul; 8(3):424-33. PubMed ID: 25890881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Policy implications of Medicare Part D for adults with mental illness: a qualitative exploration.
    Hensley MA
    Soc Work Public Health; 2012; 27(3):238-49. PubMed ID: 22486429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Prescription Drug Insurance and Health Care Utilization Among Medicare Beneficiaries.
    Alexander GC; Schiman C; Kaestner R
    Med Care Res Rev; 2018 Apr; 75(2):153-174. PubMed ID: 29148319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outpatient prescription drug utilization and expenditure patterns of noninstitutionalized aged Medicare beneficiaries.
    LaVange LM; Silverman HA
    Natl Med Care Util Expend Surv B; 1987 Apr; (12):1-43. PubMed ID: 10313516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of prescription drug expenditures and medication adherence among medicare part D beneficiaries with and without the low-income supplement.
    Yala SM; Duru OK; Ettner SL; Turk N; Mangione CM; Brown AF
    BMC Health Serv Res; 2014 Dec; 14():665. PubMed ID: 25526892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in drug utilization during a gap in insurance coverage: an examination of the medicare Part D coverage gap.
    Polinski JM; Shrank WH; Huskamp HA; Glynn RJ; Liberman JN; Schneeweiss S
    PLoS Med; 2011 Aug; 8(8):e1001075. PubMed ID: 21857811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
    Patel UD; Davis MM
    J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.